FDA Approved: VYVGART — Supplemental Application (argenx US)

View source ↗

Summary

FDA approved a supplemental Biologics License Application for VYVGART (efgartigimod alfa) by argenx US, resulting in a label/indication update for its use in my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• VYVGART (EFGARTIGIMOD ALFA)

Snippet

SUPPL AP for VYVGART (EFGARTIGIMOD ALFA)